Romera-Guirado F J, Molina-Salas Y, Pérez-Martín J J, Ruzafa-Martínez M
Servicio de Salud Pública, Centro de Área de Salud III, Dirección General de Salud Pública, Consejería de Sanidad y Política Social de la Región de Murcia, Murcia, España.
Servicio de Salud Pública, Centro de Área de Salud III, Dirección General de Salud Pública, Consejería de Sanidad y Política Social de la Región de Murcia, Murcia, España.
An Pediatr (Barc). 2016 Jan;84(1):30-8. doi: 10.1016/j.anpedi.2015.02.018. Epub 2015 Apr 3.
To estimate the effectiveness of the varicella vaccine in school outbreaks during the academic year 2009-2010.
Retrospective cohort study in public day-care centers and/or schools in an area in the region of Murcia. Spain. The participants were all children of 1 to 12 years who were in the same classroom where there was an outbreak of varicella. The main measurements were the sociodemographic, clinical and vaccination data, as well as variables related to varicella disease obtained through a questionnaire self-completed by parents, and from the computerized regional immunization registry (VACUSAN).
A total of 51 varicella outbreaks were detected, with a median of 3 cases per outbreak at both educational levels. The overall vaccination coverage was 10.7% (95% CI 8.63 to 13.18), always being higher in Spanish schoolchildren versus foreign (OR: 21.21, 95% CI: 2.92 to 153.92, P<.001). Discrepancies were found between the vaccine questionnaire data and vaccination program (kappa=0.50, 95% CI: 0.43 to 0.58, P<.001). According to VACUSAN, the overall attack rate was 59.7 (95% CI: 55.82 to 63.43) in unvaccinated and 6.5 (95% CI: 2.54 to 15.45) in vaccinated children. An overall effectiveness of 89.1% (95% CI: 74.55 to 95.35) and 100% was obtained for 1 and 2 doses of vaccine, respectively.
There is a high effectiveness of varicella vaccine, emphasizing that the administration of two doses of vaccine produces an adequate and optimal protection against varicella disease. A discrepancy was found between the information provided by parents and official records. Finally, there was a lower vaccination coverage in the immigrant community.
评估2009 - 2010学年水痘疫苗在学校水痘暴发疫情中的有效性。
对西班牙穆尔西亚地区某一区域的公立日托中心和/或学校进行回顾性队列研究。研究对象为1至12岁、在同一教室发生水痘暴发疫情的所有儿童。主要测量指标包括社会人口统计学、临床和疫苗接种数据,以及通过家长自行填写的问卷和地区计算机化免疫登记系统(VACUSAN)获得的与水痘疾病相关的变量。
共检测到51起水痘暴发疫情,两个教育层面每次暴发疫情的病例数中位数均为3例。总体疫苗接种覆盖率为10.7%(95%置信区间8.63至13.18),西班牙学龄儿童的接种覆盖率始终高于外国儿童(比值比:21.21,95%置信区间:2.92至153.92,P <.001)。在疫苗问卷数据和疫苗接种计划之间发现了差异(kappa = 0.50,95%置信区间:0.43至0.58,P <.001)。根据VACUSAN,未接种疫苗儿童的总体发病率为59.7(95%置信区间:55.82至63.43),接种疫苗儿童的发病率为6.5(95%置信区间:2.54至15.45)。1剂和2剂疫苗的总体有效性分别为89.1%(95%置信区间:74.55至95.35)和100%。
水痘疫苗具有很高的有效性,强调接种两剂疫苗可对水痘疾病产生充分且最佳的保护。发现家长提供的信息与官方记录之间存在差异。最后,移民社区的疫苗接种覆盖率较低。